5
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Monthly Update: Anti-infectives: In vitro activity of quinupristin/dalfopristin (RP 59500) against Gram-positive pathogens: An update

&
Pages 357-363 | Published online: 03 Mar 2008

References

  • BARRIERE JC, BOUANCHAUD DH, DESNOlIES JF, PARIS JM: Streptogramin analogues. E7cp. Opin. Invest. Drugs (1994) 3(2)115–131.
  • AUMERCIER M, BOUHALLAB S, CAPMAU ML, LE GOFFIC F:RP 59500: a proposed mechanism for its bactericidal activity. J. Antimicrob. Chemother. (1992) 30(Suppl. A):9–14.
  • COCITO C, DI GIAMBATTISTA M, VANNUFFEL P: Themechanism of action of streptogramins. 3rd Interna-tional Conference on the Macrolides, Azalides and Strepto-gramins. Lisbon (1996). Abstract 12.
  • BARRIERE JC, BOUANCHAUD DH, PARIS JM, ROLIN 0,HARRIS NV, SMITH C: Antimicrobial activity against Staphylococcus aureus of semisynthetk injectable streptogramlns: RP 59500 and related compounds. J. Antimicrob. Chemother. (1992) 30(Suppl. A):1–8,
  • SHONEKAN D, HANDWERGER S, MILDVAN D: Compara-tive in vitro activities of RP 59500 (quinupristin/dalfo-pristin), CL 329,998, CL 331,002, CP-99,219, clinafloxacin, tekoplanin and vancomycin against Gram-positive bacteria. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract E124.
  • REINERT R, KRESKEN M, LEMPERLE M, LUTTICKEN R: Invitro antibacterial activity of RP 59500 (quinupristin/dalfopristin), a setnisynthetic strepto-gramin combination, against Streptococcus pneumo-niae. 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon (1996). Abstract 3.15.
  • PANKUCH GA, JACOBS MR, APPELBAUM PC: Antipneu-mococcal activity of RP 59500 (an injectable strepto-gramin), erythromycin and sparfloxadn by MIC and rapid time-kill. 35th Interscience Conference on Antimicro-bial Agents and Chemotherapy. San Francisco (1995). Ab-stract E117.
  • TARASI A, TOMASZ A: Activity of RP 59500 againstmultidrug resistant clones of Streptococcus pneumo-niae. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract E116.
  • DEVER L, TARASI A, TOMASZ A: Bactericidal activity ofRP 59500(RP)againstStreptococcuspneuntoniae in the rabbit model of experimental meningitis. 3rd Interna-tional Conference on the Macrolides, Azalides and Strepto-gramins. Lisbon (1996). Abstract 3.31.
  • VON EIFF C, PETERS G: The in vitro activity of RP 59500,a new semisynthetic injectable pristinamycin, against staphylococci. 3rd International Conference on the Macrolides, Azalides and Streptogramins. Lisbon (1996). Abstract 3.25.
  • BERTHAUD N, CHARLES Y, GOUIN AM, HOUDEBINE C,ROUSSEAU J, DESNOTTES JF: In vitro bacteriddal activity of RP 59500 (quinupristin/dalfopristin) against adher-ent Staphylococcus aureus. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract E122.
  • HAMILTON-MILLER JMT, SHAH 5: Killing of Staphylococ-cus epidermidis in biofilm by RP 59500 (quinupristin/dalfopristin) and other antibiotics. 35th Interscience Conference on Antimicrobial Agents and Che-motherapy. San Francisco (1995). Abstract A104.
  • BOSWELL FJ, SUNDERLAND J, ANDREWS JM, WISER: Timekill kinetics of RP 59500 (quinupristin/dalfopristin) on Staphylococcus aureus with and without a raised MBC evaluated using two methods. 35th Interscience Confer-ence on Antimicrobial Agents and Chemotherapy. San Fran-cisco (1995). Abstract E123.
  • GRIMM H: In Wow activity of quinupristin/dalfopristin (RP 59500) and 8 other antibiotics against Enterococcus faecium. 3rd International Conference on the Macro/ides, Azalides and Streptogramins. Lisbon (1996). Abstract 6.18.
  • HILL RLR, SMITH C, CASEWELL MW: Bactericidal and inhibitory activity of RP 59500 (quinupristin/dalfo-pristin) and its components against vancomycin- and gentamicin-resistant Enterococcus faecium. 35th Inter-science Conference on Antimicrobial Agents and Chemother-apy. San Francisco (1995). Abstract E118.
  • WILLIAMS JD, MASKELL JP, WHILEY AC, SEFTON AM: Comparative in vitro activity of RP 59500 (quinupristin/dalfopristin) against Enterococcus spp. 3rd International Conference on the Macro/ides, Azalides and Streptogramins. Lisbon (1996). Abstract 6.19.
  • CARON F, GOLD HS, WENNERSTEN CB, MOELLERING RC, Jr., ELIOPOULOS GM: Role of growth phase and of susceptibility to erythromycin on the bactericidal effect of RP 59500, a combination of quinupristin and daffo-pristin, against vancomycin-resistant Enterococcus faecium strains. 3rd International Conference on the Macro/ides, Azalides and Streptogramins. Lisbon (1996), Abstract 6.17.
  • KANG SL, RYBAK MJ: In vitro bactericidal activity of RP59500 (quinupristin/dalfopristin) alone and in various combinations against resistant strains of Enterococcus species and Staphylococcus aureus. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract E121.
  • LORIAN V, FERNANDES F: Synergistic activity of inject- able streptogramin RP 59500 (quinupristin/dalfo-pristin) - vancomycin combination. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract E126.
  • HERRERA-INSUA I, JACQUES-PALAZ K, MURRAY BE, RAKITA RM: Intracellular activity of RP 59500 (quinupristin/daffopristin), an injectable strepto-gramin, againstEnterococcusfaecium. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract E119.
  • WEISBLUM B: Inducible resistance to macrolides, lin-cosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity and struc-tural elements that regulate expression - a review. J. Antimicrob. Chemotber. (1985) 16(Suppl. A):63–90.
  • ALLIGNET J, LONCLE V, EL SOLH: Sequence of a staphy-lococcal gene, vat, encoding an acetyltransferase inac-tivating streptogramin A and related antibiotics (RP 54476). 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans (1993). Abstract 218.
  • LECLERCQ R, NANTAS L, SOUSSY CJ, DUVAL J: Activity of RP 59500, a new parenteral semisynthetic strepto-gramin, against staphylococci with various mecha-nisms of resistance to macrolide-lincosamide-streptogratnin antibiotics. J. Antimicrob. Chernother. (1992) 30(Suppl. A):67–75.
  • EL SOLH N, LONCLE V, AUBERT A, CASETTA A, ALLIGNET J: Analysis of staphylococcal elements conferring resis-tance to streptogramin A (RP 54476). 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans (1993). Abstract 217.
  • MILLICHAP J, RISTOW T, NOSKIN G, PETERSON L: Selec-tion of Enterococcus faecium strains with stable and unstable resistance to RP 59500 (quinupristin/dalfo-pristin) using step-wise exposure in vitro. 35th Inter-science Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract E120.
  • TENOVER FC, BAKER CN: Development of provisional disk diffusion breakpoints for testing RP 59500 (quinupristin/daffopristin). 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco (1995). Abstract D30.
  • NEU HC, CHIN N, GU J: The in vitro activity of new streptograrnins, RP 59500, RP 57669 and RP 54476, alone and in combination. J. Antimicrob. Chemother. (1992) 30(Suppl. A):83–94.
  • DUBOIS J, JOLY JR: In vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp. J. Antimicrob. Chemother. (1992) 30(Suppl. A:77–81.
  • RENAUDIN H, BOUSSENS B, BEBEAR C: In vitro activity of RP 59500 against Mycoplasma. 31st Interscience Con-ference on AntimicrobialAgents and Chemotherapy. Chicago (1991). Abstract 897.
  • NOUGAYREDE A, BERTHAUD N, BOUANCHAUD DH: Post-antibiotic effects of RP 59500 withStapbylococcus aureus. J. Antimicrob. Chemother. (1992) 30(Suppl. A):101–106.
  • CRAIG W, EBERT S: Pharmacodynamic activities of RP59500 in an animal infection modeL 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans (1995). Abstract 470.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.